10th antibody industrial symposium: new developments in antibody and adoptive cell therapies - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100 Access content directly
Journal Articles mAbs Year : 2023

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

Stéphanie Cornen
  • Function : Author
Thierry Wurch
  • Function : Author
Alain Beck

Abstract

The annual "Antibody Industrial Symposium", co-organized by LabEx MAbImprove and MabDesign, held its 10th anniversary edition in Montpellier, France, on June 28-29, 2022. The meeting focused on new results and concepts in antibody engineering (naked, mono- or multi-specific, conjugated to drugs or radioelements) and also on new cell-based therapies, such as chimeric antigenic receptor (CAR)-T cells. The symposium, which brought together scientists from academia and industry, also addressed issues concerning the production of these molecules and cells, and the necessary steps to ensure a strong intellectual property protection of these new molecules and approaches. These two days of exchanges allowed a rich discussion among the various actors in the field of therapeutic antibodies.
Fichier principal
Vignette du fichier
10th antibody industrial symposium new developments in antibody and adoptive cell therapies.pdf (811.03 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
licence : CC BY NC - Attribution - NonCommercial

Dates and versions

hal-04121982 , version 1 (08-06-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Ana Antunes, Luis Álvarez-Vallina, Federico Bertoglio, Nicolas Bouquin, Stéphanie Cornen, et al.. 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. mAbs, 2023, 15 (1), pp.2211692. ⟨10.1080/19420862.2023.2211692⟩. ⟨hal-04121982⟩
508 View
61 Download

Altmetric

Share

Gmail Facebook X LinkedIn More